UCB Visited by Chinese Authorities Amid Glaxo Probe
This article is for subscribers only.
UCB SA’s Chinese operations were visited by local authorities following the government’s probe of GlaxoSmithKline Plc over allegations of economic crimes.
All drugmakers are receiving visits, and the Brussels-based company has “nothing to report,” France Nivelle, a UCB spokeswoman, said yesterday in an interview. “It’s business as usual,” Nivelle said. Reuters had reported the visit earlier.